LifeVantage Approves a New Cash Dividend
LifeVantage Corporation (NASDAQ: LFVN), recognized as a leader in health and wellness, has announced an exciting development for its shareholders. The Board of Directors has declared a quarterly cash dividend of $0.04 for each share of common stock. This dividend will directly benefit stockholders and is slated for payment on December 16, 2024. Stockholders who hold shares at the close of business on December 2, 2024, will be eligible for this dividend.
Understanding LifeVantage's Mission
LifeVantage Corporation is often referred to as the Activation company, largely due to its pioneering work in the field of nutrigenomics. This innovative science focuses on how nutrition interacts with our genes, promoting optimal health at the cellular level. With a variety of products tailored to enhance wellness, LifeVantage empowers individuals to take control of their health. The approach is not merely to provide supplements; it’s about unlocking the body’s potential through scientifically-backed products.
Key Products and Innovations
The lineup of LifeVantage products is impressive and includes several well-known brands. The Protandim family of products stands out as a flagship line that has undergone rigorous scientific validation. Additionally, products such as the TrueScience Liquid Collagen have gained popularity among users seeking to improve their skin’s appearance. LifeVantage also offers the MindBody GLP-1 System™ and various nutrients like Omega and D3+ that support overall well-being. Their well-received AXIO nootropic energy drinks provide a quick and convenient boost for busy lifestyles.
LifeVantage's Commitment to Quality
What sets LifeVantage apart is their commitment to quality and efficacy. Each product is developed with the unique biology of customers in mind, ensuring that their health needs are met more effectively. This commitment extends to their independent Consultants, who are dedicated to sharing products and business opportunities with aspiring entrepreneurs.
Corporate Values and Community Engagement
Founded in 2003 and headquartered in Lehi, Utah, LifeVantage stands by the values of integrity, education, and support. The company actively engages in community initiatives, working towards improving health and wellness beyond just their product offerings. As a socially-conscious organization, they cherish their relationship with both customers and consultants alike, emphasizing a community-oriented approach.
Contacting Investor Relations
For shareholders interested in more details regarding dividends or overall company performance, the Investor Relations team is available to assist. Reed Anderson from ICR can be reached at (646) 277-1260 or via email at reed.anderson@icrinc.com for any queries. They encourage open communication, ensuring all stakeholders remain informed about the business's trajectory.
Conclusion: Looking Forward
The recent dividend declaration is a testament to LifeVantage’s solid financial foundation and the company’s growth strategy. It illustrates their dedication to returning value to shareholders while continuing to innovate and expand their product offerings. As LifeVantage charts its future, it remains focused on enhancing customers' health and well-being, creating an impactful legacy in the health industry.
Frequently Asked Questions
What is the amount of the dividend declared by LifeVantage?
The Board of Directors declared a quarterly cash dividend of $0.04 per share.
When will the dividend be paid out?
The dividend will be paid on December 16, 2024, to stockholders on record as of December 2, 2024.
What products does LifeVantage offer?
LifeVantage offers a range of health-focused products including Protandim, TrueScience Liquid Collagen, and AXIO energy drinks.
What is LifeVantage's focus?
LifeVantage specializes in nutrigenomics, aiming to enhance health and wellness at a cellular level through innovative products.
How can I contact LifeVantage's investor relations?
Investor Relations can be reached through Reed Anderson at (646) 277-1260 or by email at reed.anderson@icrinc.com.
